Raju Titus Chacko Selected Research

Raju Titus Chacko Research Topics

4	Neoplasms (Cancer) 07/2023 - 01/2021
3	Triple Negative Breast Neoplasms 11/2023 - 06/2022
3	Breast Neoplasms (Breast Cancer) 06/2022 - 04/2016
2	Adenocarcinoma 07/2023 - 01/2021
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2022 - 01/2014
1	Rectal Neoplasms (Rectal Cancer) 07/2023
1	Signet Ring Cell Carcinoma 07/2023
1	Seminoma 10/2022
1	Thrombocytopenia (Thrombopenia) 06/2022
1	Anemia 06/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Hand-Foot Syndrome 04/2016
1	Exanthema (Rash) 04/2016
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Cystic Mesothelioma 04/2013

3	Docetaxel (Taxotere)FDA Link 10/2023 - 01/2021
3	PlatinumIBA 10/2023 - 12/2017
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 06/2022
2	Epirubicin (Ellence)FDA LinkGeneric 10/2023 - 06/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 06/2022
1	Trinitrotoluene (TNT)IBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 06/2022
1	Pemetrexed (MTA)FDA Link 11/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	human ERBB2 proteinIBA 01/2021
1	5-fluorodihydrouracilIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	ErbB Receptors (EGF Receptor)IBA 12/2017
1	Hormones (Hormone)IBA 04/2016
1	Everolimus FDA Link 04/2016
1	TOR Serine-Threonine KinasesIBA 04/2016
1	AsbestosIBA 04/2013

8	Drug Therapy (Chemotherapy) 07/2023 - 01/2014
3	Neoadjuvant Therapy 11/2023 - 01/2021
2	Therapeutics 01/2021 - 04/2016
1	Chemoradiotherapy 07/2023
1	TNT protocol 07/2023
1	Blood Transfusion (Blood Transfusions) 06/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Adjuvant Chemotherapy 01/2021